Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification

BACKGROUND: Cholangiocarcinoma is a rare but lethal cancer of the biliary tract. Its first-line treatment is currently restricted to chemotherapy, which provides limited clinical benefit. Kinase inhibitors targeting oncogenic intracellular signaling have changed the treatment paradigm of cancer over...

Descripción completa

Detalles Bibliográficos
Autores principales: Lieshout, Ruby, Faria, Alessandra V. S., Peppelenbosch, Maikel P., van der Laan, Luc J. W., Verstegen, Monique M. A., Fuhler, Gwenny M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238224/
https://www.ncbi.nlm.nih.gov/pubmed/35764936
http://dx.doi.org/10.1186/s10020-022-00498-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238224/
https://www.ncbi.nlm.nih.gov/pubmed/35764936
http://dx.doi.org/10.1186/s10020-022-00498-1

Ejemplares similares